Novo’s Wegovy Pill Crushes Lilly’s Foundayo in Early Weight-Loss Battle
Novo Nordisk’s Wegovy pill is dominating early sales with 8x more prescriptions than Eli Lilly’s Foundayo.
/ 97 items
#NVO↓
Avere Therapeutics Debuts on Nasdaq Backed by Ex-Akero Leaders Behind Novo Nordisk Acquisition
The company just went public via a $320M reverse merger with NextCure and is advancing a promising once-weekly oral IL-23 inhibitor for psoriasis and ulcerative colitis.
JPMorgan Raises Eli Lilly Price Target to $1,400 on Mounjaro’s Obesity and Pediatric Momentum
Health Canada has approved Mounjaro for children with type 2 diabetes.
Eli Lilly Stock Surges as Retatrutide Delivers 28% Weight Loss and Major Relief for Sleep Apnea & Knee Pain
Lilly stock jumps as new obesity drug helps people lose ~30% body weight and improve health, showing strong promise for future treatment.
Enobosarm Grabs Novo Nordisk’s Attention: Veru’s Big Obesity Breakthrough
Veru partnered with Novo Nordisk to test enobosarm + Wegovy for fat loss while keeping muscle; stock surged.
Hims & Hers Now Offers Affordable Generic Semaglutide in Canada
Hims & Hers offers cheaper generic semaglutide in Canada ($149/mo) with medical support for weight loss care.